95
The use of NCCN guideline therapy in the first line/adjuvant setting in patients with ovarian cancer from 6 NCCN Institutions
Sunday, March 29, 2015: 3:05 PM
Salon C-D (Hilton Chicago)
D. M. O'Malley1, J. Niland2, M. A. Bookman3, R. A. Burger4, M. Cristea2, J. Griggs5, G. M. Mantia-Smaldone6, L. A. Meyer7, C. C. L. Sun7, A. Wright8 and D. E. Cohn1
1The Ohio State University, James Cancer Hospital, Columbus, OH, 2City of Hope, Duarte, CA, 3University of Arizona Cancer Center, Tucson, AZ, 4University of Pennsylvania, Philadelphia, PA, 5University of Michigan Health Systems, Ann Arbor, MI, 6Fox Chase Cancer Center, Philadelphia, PA, 7The University of Texas MD Anderson Cancer Center, Houston, TX, 8Brigham and Women's Hospital/Dana Farber Cancer Institute, Boston, MA
